177Lu-BRP-020063
/ BoomRay Pharmaceuticals
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 28, 2026
Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
New P1 trial • Breast Cancer • Oncology • Solid Tumor • Urothelial Cancer
1 to 1
Of
1
Go to page
1